Dominantly Inherited Stargardt's Disease (STGD3)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Dominantly Inherited Stargardt's Disease (STGD3) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT00420602

DHA Supplementation in Patients With STGD3

We have found that biomarkers of long-term elevated dietary intake of omega-3 fatty acids such as DHA and EPA are inversely associated with severity of disease…

United States11 participantsStarted 2007-09-21

Treatment: Over the counter DHA/EPA dietary supplementation